GleamWall
中文EN

PRAX Praxis Precision Medicines, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1689548 · Fiscal year ends 12/31

Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY365.0%
TTM net income YoY-80.8%
TTM EPS YoY-41.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-3,927.5%
Net margin-3,658.5%
FCF margin-3,067.4%
EBITDA margin-3,925.4%

Returns

ROE-75.2%
ROA-67.2%
ROIC (approx.)-113.5%
Asset turnover0.02x

Leverage & solvency

Liabilities / assets13.3%
Debt / equity0.00x
Current ratio5.18x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.84x
Accruals ratio-10.9%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$8.55M
R&D expense$267.12M$152.41M
SG&A expense$59.08M$56.30M
Operating income-$326.20M-$200.16M
Pretax income-$302.80M-$182.74M
Income tax$471,000—
Net income-$303.27M-$182.82M
EBITDA-$326.06M-$199.81M
EPS (basic)-13.48-10.21
EPS (diluted)-13.48-10.21
Weighted avg. shares (diluted)22.50M17.91M
Balance sheet
Cash & equivalents$357.33M$215.79M
Short-term investments$242.00M$177.19M
Current assets$610.91M$404.37M
PP&E, net$147,000$230,000
Intangibles$0—
Total assets$937.91M$483.11M
Current liabilities$59.77M$37.55M
Total liabilities$59.77M$37.66M
Shareholders' equity$878.14M$445.45M
Shares outstanding25.20M19.42M
Cash flow statement
Operating cash flow-$249.07M-$131.76M
Capital expenditure$56,000$0
Free cash flow-$249.12M-$131.76M
Investing cash flow-$311.15M-$248.49M
Financing cash flow$702.17M$514.32M
Depreciation & amortization$140,000$358,000
Stock-based compensation$33.94M$41.36M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.